Airbus posts strong first-half commercial performance despite supply chain challenges

Airbus SE has reported consolidated financial results for the first half of 2025, highlighting strong commercial performance despite supply chain challenges affecting aircraft deliveries.

Chief Executive Officer Guillaume Faury said the results reflected progress in the Defence and Space division and ongoing issues with engine supply for the A320 programme, which have pushed deliveries to the second half of the year. He welcomed the recent political agreement between the EU and the US to remove tariffs on civil aircraft but confirmed that Airbus’ 2025 guidance remains unchanged and excludes tariff impacts.

Gross commercial aircraft orders rose sharply to 494 compared with 327 in the first half of 2024. After cancellations, net orders stood at 402 aircraft, up from 310 a year earlier. Airbus’ order backlog reached 8,754 commercial aircraft at the end of June 2025. Airbus Helicopters booked net orders for 171 units, down from 233 last year, while Airbus Defence and Space recorded order intake worth €5.1 billion compared with €6.1 billion in 2024.

Consolidated revenues increased by 3% to €29.6 billion (H1 2024: €28.8 billion). Deliveries of 306 commercial aircraft, compared with 323 in the same period of 2024, comprised 41 A220s, 232 A320 family, 12 A330s and 21 A350s. Revenues from commercial aircraft activities fell 2% to €20.8 billion due to lower deliveries, while Airbus Helicopters’ revenues grew 16% to €3.7 billion on the back of strong programmes and services. Airbus Defence and Space reported a 17% revenue increase to €5.8 billion, driven by higher volumes across all business lines.

Consolidated EBIT Adjusted rose to €2,204 million from €1,391 million a year earlier, which included €989 million of charges in the Space Systems business. EBIT Adjusted from commercial aircraft activities was €1,714 million from 1,954 million the previous year, reflecting fewer deliveries but benefiting from favourable hedge rates and lower R&D spending.